{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:16:32Z","timestamp":1791314192541,"version":"4.3.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T00:00:00Z","timestamp":1545868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T00:00:00Z","timestamp":1545868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2019,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Risk assessment and therapeutic options are challenges when counselling patients with an atypical ductal hyperplasia (ADH) to undergo either open surgery or follow-up only.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed a series of ADH lesions and assessed whether the morphological parameters of the biopsy materials indicated whether the patient should undergo surgery. A total of 207 breast biopsies [56 core needle biopsies (CNBs) and 151 vacuum-assisted biopsies (VABs)] histologically diagnosed as ADH were analyzed retrospectively, together with subsequently obtained surgical specimens. All histological slides were re-analyzed with regard to the presence\/absence of ADH-associated calcification, other B3 lesions (lesion of uncertain malignant potential), extent of the lesion, and the presence of multifocality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The overall underestimation rate for the whole cohort was 39% (57% for CNB, 33% for VAB). In the univariate analysis, the method of biopsy (CNB vs VAB,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002) and presence of multifocality in VAB specimens (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0176) were significant risk factors for the underestimation of the disease (ductal carcinoma in situ or invasive cancer detected on subsequent open biopsy). In the multivariate logistic regression model, the absence of calcification (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0252) and the presence of multifocality (unifocal vs multifocal ADH,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0147) in VAB specimens were significant risk factors for underestimation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Multifocal ADH without associated calcification diagnosed by CNB tends to have a higher upgrade rate. Because the upgrade rate was 16.5% even in the group with the lowest risk (VAB-diagnosed unifocal ADH with calcification), we could not identify a subgroup that would not require an open biopsy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12282-018-00943-2","type":"journal-article","created":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T06:03:21Z","timestamp":1545890601000},"page":"452-458","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Atypical ductal hyperplasia and the risk of underestimation: tissue sampling method, multifocality, and associated calcification significantly influence the diagnostic upgrade rate based on subsequent surgical specimens"],"prefix":"10.1007","volume":"26","author":[{"given":"Christoph J.","family":"Rageth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravit","family":"Rubenov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Bronz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Tausch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Katrin","family":"Rodewald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsanna","family":"Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,27]]},"reference":[{"issue":"1","key":"943_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.humpath.2010.06.011","volume":"42","author":"KH Allison","year":"2011","unstructured":"Allison KH, Eby PR, Kohr J, DeMartini WB, Lehman CD. Atypical ductal hyperplasia on vacuum-assisted breast biopsy: suspicion for ductal carcinoma in situ can stratify patients at high risk for upgrade. Hum Pathol. 2011;42(1):41\u201350.","journal-title":"Hum Pathol"},{"issue":"12","key":"943_CR2","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1158\/1940-6207.CAPR-11-0478","volume":"4","author":"DC Allred","year":"2011","unstructured":"Allred DC. Molecular biomarkers of risk in premalignancy and breast cancer prevention. Cancer Prev Res (Phila). 2011;4(12):1947\u201352.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"4","key":"943_CR3","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1245\/s10434-011-2053-0","volume":"19","author":"TA King","year":"2012","unstructured":"King TA, Sakr RA, Muhsen S, Andrade VP, Giri D, Van Zee KJ, et al. Is there a low-grade precursor pathway in breast cancer? Ann Surg Oncol. 2012;19(4):1115\u201321.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"943_CR4","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nrclinonc.2015.8","volume":"12","author":"M Morrow","year":"2015","unstructured":"Morrow M, Schnitt SJ, Norton L. Current management of lesions associated with an increased risk of breast cancer. Nat Rev Clin Oncol. 2015;12(4):227\u201338.","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"943_CR5","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.breast.2010.12.003","volume":"20","author":"S Bianchi","year":"2011","unstructured":"Bianchi S, Caini S, Renne G, Cassano E, Ambrogetti D, Cattani MG, et al. Positive predictive value for malignancy on surgical excision of breast lesions of uncertain malignant potential (B3) diagnosed by stereotactic vacuum-assisted needle core biopsy (VANCB): a large multi-institutional study in Italy. Breast. 2011;20(3):264\u201370.","journal-title":"Breast"},{"issue":"1","key":"943_CR6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1080\/00313020802568097","volume":"41","author":"JF Simpson","year":"2009","unstructured":"Simpson JF. Update on atypical epithelial hyperplasia and ductal carcinoma in situ. Pathology. 2009;41(1):36\u20139.","journal-title":"Pathology"},{"issue":"5","key":"943_CR7","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/j.1365-2559.2005.02246.x","volume":"47","author":"TC Putti","year":"2005","unstructured":"Putti TC, Pinder SE, Elston CW, Lee AH, Ellis IO. Breast pathology practice: most common problems in a consultation service. Histopathology. 2005;47(5):445\u201357.","journal-title":"Histopathology"},{"issue":"2","key":"943_CR8","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10549-016-3935-4","volume":"159","author":"CJ Rageth","year":"2016","unstructured":"Rageth CJ, O\u2019Flynn EA, Comstock C, Kurtz C, Kubik R, Madjar H, et al. First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions). Breast Cancer Res Treat. 2016;159(2):203\u201313.","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"943_CR9","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1097\/PAS.0b013e318161d1a5","volume":"32","author":"TM Abdel-Fatah","year":"2008","unstructured":"Abdel-Fatah TM, Powe DG, Hodi Z, Reis-Filho JS, Lee AH, Ellis IO. Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: further evidence to support the concept of low nuclear grade breast neoplasia family. Am J Surg Pathol. 2008;32(4):513\u201323.","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"943_CR10","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1158\/1940-6207.CAPR-10-0242","volume":"4","author":"FE Barr","year":"2011","unstructured":"Barr FE, Degnim AC, Hartmann LC, Radisky DC, Boughey JC, Anderson SS, et al. Estrogen receptor expression in atypical hyperplasia: lack of association with breast cancer. Cancer Prev Res (Phila). 2011;4(3):435\u201344.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"4","key":"943_CR11","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s10911-010-9195-8","volume":"15","author":"MA Cichon","year":"2010","unstructured":"Cichon MA, Degnim AC, Visscher DW, Radisky DC. Microenvironmental influences that drive progression from benign breast disease to invasive breast cancer. J Mammary Gland Biol Neoplasia. 2010;15(4):389\u201397.","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"6","key":"943_CR12","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1309\/3XYV8FN4NPY1TBTW","volume":"124","author":"O Hameed","year":"2005","unstructured":"Hameed O, Ghali VS, Tartter PI, Mizrachi H. Immunohistochemical staining for cyclin D1 and Ki-67 aids in the stratification of atypical ductal hyperplasia diagnosed on breast core biopsy. Am J Clin Pathol. 2005;124(6):862\u201372.","journal-title":"Am J Clin Pathol"},{"key":"943_CR13","doi-asserted-by":"publisher","first-page":"489064","DOI":"10.4061\/2011\/489064","volume":"2011","author":"A Nasir","year":"2011","unstructured":"Nasir A, Chen DT, Gruidl M, Henderson-Jackson EB, Venkataramu C, McCarthy SM, et al. Novel molecular markers of malignancy in histologically normal and benign breast. Pathol Res Int. 2011;2011:489064.","journal-title":"Pathol Res Int"},{"issue":"1","key":"943_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.soc.2017.07.011","volume":"27","author":"JM Racz","year":"2018","unstructured":"Racz JM, Degnim AC. When does atypical ductal hyperplasia require surgical excision? Surg Oncol Clin N Am. 2018;27(1):23\u201332.","journal-title":"Surg Oncol Clin N Am"},{"issue":"2","key":"943_CR15","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s11547-011-0626-9","volume":"116","author":"A Ancona","year":"2011","unstructured":"Ancona A, Capodieci M, Galiano A, Mangieri F, Lorusso V, Gatta G. Vacuum-assisted biopsy diagnosis of atypical ductal hyperplasia and patient management. Radiol Med. 2011;116(2):276\u201391.","journal-title":"Radiol Med"},{"key":"943_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ijsu.2017.11.005","volume":"49","author":"M Co","year":"2018","unstructured":"Co M, Kwong A, Shek T. Factors affecting the under-diagnosis of atypical ductal hyperplasia diagnosed by core needle biopsies\u2014a 10-year retrospective study and review of the literature. Int J Surg. 2018;49:27\u201331.","journal-title":"Int J Surg"},{"issue":"9","key":"943_CR17","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1038\/modpathol.2011.73","volume":"24","author":"I de Mascarel","year":"2011","unstructured":"de Mascarel I, Brouste V, Asad-Syed M, Hurtevent G, Macgrogan G. All atypia diagnosed at stereotactic vacuum-assisted breast biopsy do not need surgical excision. Mod Pathol. 2011;24(9):1198\u2013206.","journal-title":"Mod Pathol"},{"issue":"3","key":"943_CR18","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/modpathol.2017.114","volume":"31","author":"G Farshid","year":"2017","unstructured":"Farshid G, Edwards S, Kollias J, Gill PG. Active surveillance of women diagnosed with atypical ductal hyperplasia on core needle biopsy may spare many women potentially unnecessary surgery, but at the risk of undertreatment for a minority: 10-year surgical outcomes of 114 consecutive cases from a single center. Mod Pathol. 2017;31(3):395\u2013405.","journal-title":"Mod Pathol."},{"issue":"2","key":"943_CR19","doi-asserted-by":"publisher","first-page":"W132-40","DOI":"10.2214\/AJR.11.7799","volume":"198","author":"S Krishnamurthy","year":"2012","unstructured":"Krishnamurthy S, Bevers T, Kuerer H, Yang WT. Multidisciplinary considerations in the management of high-risk breast lesions. AJR Am J Roentgenol. 2012;198(2):W132-40.","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"943_CR20","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1245\/s10434-010-1127-8","volume":"18","author":"CV Nguyen","year":"2011","unstructured":"Nguyen CV, Albarracin CT, Whitman GJ, Lopez A, Sneige N. Atypical ductal hyperplasia in directional vacuum-assisted biopsy of breast microcalcifications: considerations for surgical excision. Ann Surg Oncol. 2011;18(3):752\u201361.","journal-title":"Ann Surg Oncol"},{"key":"943_CR21","unstructured":"Lakhani SEEI, Schnitt SJ, Tan PH, van de Vivjer MJ. WHO classification of tumors of the breast. 4th ed. WHO Press, Geneva."},{"issue":"Suppl 2","key":"943_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/modpathol.2010.56","volume":"23","author":"IO Ellis","year":"2010","unstructured":"Ellis IO. Intraductal proliferative lesions of the breast: morphology, associated risk and molecular biology. Mod Pathol. 2010;23(Suppl 2):1\u20137.","journal-title":"Mod Pathol"},{"issue":"4","key":"943_CR23","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1046\/j.1365-2559.2003.01582.x","volume":"42","author":"AH Lee","year":"2003","unstructured":"Lee AH, Denley HE, Pinder SE, Ellis IO, Elston CW, Vujovic P, et al. Excision biopsy findings of patients with breast needle core biopsies reported as suspicious of malignancy (B4) or lesion of uncertain malignant potential (B3). Histopathology. 2003;42(4):331\u20136.","journal-title":"Histopathology"},{"issue":"1","key":"943_CR24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1590\/0100-3984.2014.0110","volume":"49","author":"GM Badan","year":"2016","unstructured":"Badan GM, Roveda Junior D, Piato S, Fleury Ede F, Campos MS, Pecci CA, et al. Diagnostic underestimation of atypical ductal hyperplasia and ductal carcinoma in situ at percutaneous core needle and vacuum-assisted biopsies of the breast in a Brazilian reference institution. Radiol Bras. 2016;49(1):6\u201311.","journal-title":"Radiol Bras"},{"issue":"3","key":"943_CR25","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1148\/radiol.09091406","volume":"255","author":"JR Kohr","year":"2010","unstructured":"Kohr JR, Eby PR, Allison KH, DeMartini WB, Gutierrez RL, Peacock S, et al. Risk of upgrade of atypical ductal hyperplasia after stereotactic breast biopsy: effects of number of foci and complete removal of calcifications. Radiology. 2010;255(3):723\u201330.","journal-title":"Radiology"},{"issue":"1","key":"943_CR26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/MAJ.0b013e318234cc67","volume":"344","author":"AK Polat","year":"2012","unstructured":"Polat AK, Kanbour-Shakir A, Andacoglu O, Polat AV, Johnson R, Bonaventura M, et al. Atypical hyperplasia on core biopsy: is further surgery needed? Am J Med Sci. 2012;344(1):28\u201331.","journal-title":"Am J Med Sci"},{"issue":"2","key":"943_CR27","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s10549-017-4253-1","volume":"164","author":"A Pena","year":"2017","unstructured":"Pena A, Shah SS, Fazzio RT, Hoskin TL, Brahmbhatt RD, Hieken TJ, et al. Multivariate model to identify women at low risk of cancer upgrade after a core needle biopsy diagnosis of atypical ductal hyperplasia. Breast Cancer Res Treat. 2017;164(2):295\u2013304.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"943_CR28","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/his.12635","volume":"67","author":"T Khoury","year":"2015","unstructured":"Khoury T, Chen X, Wang D, Kumar P, Qin M, Liu S, et al. Nomogram to predict the likelihood of upgrade of atypical ductal hyperplasia diagnosed on a core needle biopsy in mammographically detected lesions. Histopathology. 2015;67(1):106\u201320.","journal-title":"Histopathology"},{"issue":"4","key":"943_CR29","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1111\/j.1365-2559.2011.03786.x","volume":"58","author":"EA Rakha","year":"2011","unstructured":"Rakha EA, Ho BC, Naik V, Sen S, Hamilton LJ, Hodi Z, et al. Outcome of breast lesions diagnosed as lesion of uncertain malignant potential (B3) or suspicious of malignancy (B4) on needle core biopsy, including detailed review of epithelial atypia. Histopathology. 2011;58(4):626\u201332.","journal-title":"Histopathology"},{"issue":"6","key":"943_CR30","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1002\/ijc.25801","volume":"129","author":"EA Rakha","year":"2011","unstructured":"Rakha EA, Lee AH, Jenkins JA, Murphy AE, Hamilton LJ, Ellis IO. Characterization and outcome of breast needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening. Int J Cancer. 2011;129(6):1417\u201324.","journal-title":"Int J Cancer"},{"key":"943_CR31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.breast.2017.10.005","volume":"37","author":"PMY Chan","year":"2018","unstructured":"Chan PMY, Chotai N, Lai ES, Sin PY, Chen J, Lu SQ, et al. Majority of flat epithelial atypia diagnosed on biopsy do not require surgical excision. Breast. 2018;37:13\u20137.","journal-title":"Breast"},{"issue":"3","key":"943_CR32","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJMoa044383","volume":"353","author":"LC Hartmann","year":"2005","unstructured":"Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, et al. Benign breast disease and the risk of breast cancer. N Engl J Med. 2005;353(3):229\u201337.","journal-title":"N Engl J Med"}],"updated-by":[{"DOI":"10.1007\/s12282-020-01186-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T00:00:00Z","timestamp":1606262400000}}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-018-00943-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12282-018-00943-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-018-00943-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T11:22:41Z","timestamp":1610191361000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12282-018-00943-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,27]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,7,1]]}},"alternative-id":["943"],"URL":"https:\/\/doi.org\/10.1007\/s12282-018-00943-2","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,27]]},"assertion":[{"value":"4 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Christoph J. Rageth and Ravit Rubenov have equally contributed to this work.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}